MCL1 and cancer: This compound potently inhibits the association of Mcl-1 with Bak and is able to kill Mcl-1 overexpressing cancer cells, reverting Mcl-1-mediated resistance to Bcl-2/Bcl-xL/Bcl-w-selective antagonist ABT-737 [9,10].